ArticleOncoTargets and therapy2015

miR-98 targets ITGB3 to inhibit proliferation, migration, and invasion of non-small-cell lung cancer.

Ran Ni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.